Patients with serious mental illness (SMI) have a significantly increased cardiovascular risk.
Using a systematic review, the authors of this study synthesized research to examine whether criminogenic risk interventions can effectively curb criminal justice involvement for individuals with serious mental illness.
In a study, perceptual updating was assessed via a random dot motion perception task. Midway through the test, the motion direction changed. Study participants were then asked to report the direction.
Researchers conducted a meta-analysis of 26 randomized clinical trials that compared fixed doses of first- and second-generation antipsychotic medications.
Short- to intermediate-term exposure to atypical antipsychotic medications may dysregulate adaptive immune responses, increasing susceptibility to respiratory infections like COVID-19.
Adverse events, including voluntary psychiatric admission, suicide attempt, serious violent incident, voluntary admission to a general medical ward, overdose of medication or painkillers, were highest among the combined group compared to the monotherapies.
Over half of the sample attained opioids through their own prescription, and 47.2% of patients with co-occurring sedative use disorder attained sedatives by prescription.
Awareness of differences between psychosis in schizophrenia and bipolar disorder and varying presentations in patients can assist providers with diagnosis and treatment.
Researchers investigated subgroup responses to long-acting injectable medications haloperidol decanoate and paliperidone palmitate.
For patients with schizophrenia or schizoaffective disorder, younger age was significantly associated with an increased rate of readmission.